In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

European drug pricing: Jam tomorrow, log-jam today

This article was originally published in Scrip

Executive Summary

The European Parliament has agreed on potential changes to outdated European legislation that if approved could eventually bring generic medicines to the market more quickly. However, the end is by no means in sight as EU member states are still to thrash out their position on the revision, and ministers in the national governments of the European Union are understood to have a number of concerns about its contents.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC020330

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel